Injectable HDV-Rapid Acting Insulin (Diasome Pharmaceuticlas)

N/A

Report date: 2025/04/20 20:00:03

Base Information

Drug NameInjectable HDV-Rapid Acting Insulin (Diasome Pharmaceuticlas)
Drug Alias NameHDV-Insulin LisproHDV-L
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDiasome Pharmaceuticlas Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A